ArticleGynecologic oncology2017

A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers.

Kim A Reiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.